BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23846937)

  • 21. Cancer stem cells and radiotherapy: new insights into tumor radioresistance.
    Diehn M; Clarke MF
    J Natl Cancer Inst; 2006 Dec; 98(24):1755-7. PubMed ID: 17179471
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
    Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
    Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.
    Wang M; Xiao J; Jiang J; Qin R
    Int J Cancer; 2011 Apr; 128(8):1996-7. PubMed ID: 20568110
    [No Abstract]   [Full Text] [Related]  

  • 24. The complexity of identifying cancer stem cell biomarkers.
    Khan Z; Shervington A; Munje C; Shervington L
    Cancer Invest; 2013 Jul; 31(6):404-11. PubMed ID: 23758188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of stem-cell markers OCT-4 and CD133: important prognostic factors in papillary renal cell carcinoma.
    Kim K; Ro JY; Kim S; Cho YM
    Hum Pathol; 2012 Dec; 43(12):2109-16. PubMed ID: 22944295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma.
    Chen K; Li Z; Jiang P; Zhang X; Zhang Y; Jiang Y; He Y; Li X
    Oncol Rep; 2014 Aug; 32(2):755-63. PubMed ID: 24920554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Finding and killing the CRABs of pancreatic cancer.
    Caldwell ME; Tuveson DA
    Gastroenterology; 2009 Sep; 137(3):782-5. PubMed ID: 19643193
    [No Abstract]   [Full Text] [Related]  

  • 30. Automatic cell cloning assay for determining the clonogenic capacity of cancer and cancer stem-like cells.
    Fedr R; Pernicová Z; Slabáková E; Straková N; Bouchal J; Grepl M; Kozubík A; Souček K
    Cytometry A; 2013 May; 83(5):472-82. PubMed ID: 23450810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD133 as a marker for cancer stem cells: progresses and concerns.
    Wu Y; Wu PY
    Stem Cells Dev; 2009 Oct; 18(8):1127-34. PubMed ID: 19409053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver.
    Zou GM
    J Cell Physiol; 2008 Dec; 217(3):598-604. PubMed ID: 18651561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
    Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
    Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cells in the central nervous system--a critical review.
    Prestegarden L; Enger PØ
    Cancer Res; 2010 Nov; 70(21):8255-8. PubMed ID: 20959482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biology and clinical implications of CD133(+) liver cancer stem cells.
    Ma S
    Exp Cell Res; 2013 Jan; 319(2):126-32. PubMed ID: 22999864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How powerful is CD133 as a cancer stem cell marker in brain tumors?
    Cheng JX; Liu BL; Zhang X
    Cancer Treat Rev; 2009 Aug; 35(5):403-8. PubMed ID: 19369008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological and clinical relevance of stem cells in pancreatic adenocarcinoma.
    Rasheed ZA; Matsui W
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):15-8. PubMed ID: 22320910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of Expression of Cancer Stem Cell Markers CD133 and Nestin in Pancreatic Intraepithelial Carcinoma-invasive Adenocarcinoma Sequence.
    Alshenawy HA
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):205-212. PubMed ID: 32197003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic profiling of tumor-initiating cells in HT-29 human colorectal cancer cells.
    Lee HN; Park SH; Lee EK; Bernardo R; Kim CW
    Biochem Biophys Res Commun; 2012 Oct; 427(1):171-7. PubMed ID: 22995320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.
    Hermann PC; Huber SL; Herrler T; Aicher A; Ellwart JW; Guba M; Bruns CJ; Heeschen C
    Cell Stem Cell; 2007 Sep; 1(3):313-23. PubMed ID: 18371365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.